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The symbiosis between the parasitic protist Trichomonas vaginalis and the opportunistic
bacteriumMycoplasma hominis is the only one currently described involving two obligate
human mucosal symbionts with pathogenic capabilities that can cause independent
diseases in the same anatomical site: the lower urogenital tract. Although several aspects
of this intriguing microbial partnership have been investigated, many questions on the
influence of this symbiosis on the parasite pathobiology still remain unanswered. Here,
we examined with in vitro cultures how M. hominis could influence the pathobiology
of T. vaginalis by investigating the influence of M. hominis on parasite replication
rate, haemolytic activity and ATP production. By comparing isogenic mycoplasma-free
T. vaginalis and parasites stably associated with M. hominis we could demonstrate
that the latter show a higher replication rate, increased haemolytic activity and
are able to produce larger amounts of ATP. In addition, we demonstrated in a
T. vaginalis-macrophage co-culture system that M. hominis could modulate an aspect
of the innate immuno-response to T. vaginalis infections by influencing the production
of nitric oxide (NO) by human macrophages, with the parasite-bacteria symbiosis
outcompeting the human cells for the key substrate arginine. These results support
a model in which the symbiosis between T. vaginalis and M. hominis influences
host-microbes interactions to the benefit of both microbial partners during infections and
to the detriment of their host.
Keywords: Trichomonas vaginalis,Mycoplasma hominis, ATP, nitric oxide, inflammatory response, endosymbiotic
relationship
INTRODUCTION
Trichomonas vaginalis, an obligated extracellular mucosal microbial parasite, is the causative agent
of trichomoniasis, the most common cellular, curable, sexually transmitted disease worldwide
(Hobbs et al., 2008). This infection affects millions of women and men every year and the World
Health Organization estimated that in 2008 there were 276.4 million new cases (WHO, 2012). In
women, the infection ranges from asymptomatic to a severe vaginitis, and can be associated with
important complications such as pelvic inflammatory disease, sterility, pregnancy and postpartum
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problems (Petrin et al., 1998; Hobbs et al., 2008; Fichorova, 2009;
WHO, 2012; Hirt and Sherrard, 2015; Kissinger, 2015). In men,
infections occur mainly without overt symptoms, complicating
diagnosis and control of the parasite (Petrin et al., 1998;
Hobbs et al., 2008; Fichorova, 2009; Hirt and Sherrard, 2015;
Kissinger, 2015). Moreover, trichomoniasis has been associated
with invasive cervical cancer (Yap et al., 1995; Viikki et al., 2000)
and more recently with aggressive prostate cancers (Sutcliffe
et al., 2006; Twu et al., 2014). Arguably one of the most dramatic
impacts of T. vaginalis infections on human health is through its
strong epidemiological association with HIV transmission and
acquisition (Kissinger, 2015).
Trichomoniasis is linked with dysbiosis of the urogenital tract
microbiota and unbalanced inflammatory responses. Among
symptomatic patients important tissue damages can be observed
(Hirt and Sherrard, 2015; Kissinger, 2015). It is through these
different impacts on the mucosal surfaces that T. vaginalis is
thought to facilitate HIV entry and transmission (Fichorova
et al., 2013; Hirt and Sherrard, 2015; Kissinger, 2015). Indeed,
there are an increasing number of studies supporting a strong
epidemiological association between T. vaginalis and HIV
(Guenthner et al., 2005; McClelland et al., 2007; Thurman
and Doncel, 2011; Kissinger, 2015). Epidemiologic association
between T. vaginalis and other human infecting viruses are also
likely, including HPV and HSV (Tao et al., 2014; Kissinger,
2015). Other viruses of interest to consider in this context
are T. vaginalis infecting viruses member of the Totoviridae,
which in contrast to human infecting viruses can replicate
in the parasite, these are transmitted vertically (T. vaginalis
viruses, TVV) (Goodman et al., 2011). Significantly the
combination T. vaginalis-TVV could modulate the pathobiology
of the parasite by modifying parasite gene expression and
synergistically stimulating pro-inflammatory innate responses
(Fichorova et al., 2012, 2013; Hirt and Sherrard, 2015; Kissinger,
2015).
Trichomonas vaginalis can internalize members of the
bacterial microbiota through phagocytosis, potentially
contributing to vaginal dysbiosis possibly by killing differentially
members of the protective lactobacilli bacteria and by hosting
and transmitting opportunistic, pathobionts, Mollicutes
species (Bär et al., 2015). Indeed the presence of T. vaginalis
is correlated with a low abundance of protective lactobacilli
and higher proportions of Mycoplasma, Prevotella and other
bacterial species typically associated with bacterial vaginosis (BV)
(Brotman et al., 2012; Martin et al., 2013; Bär et al., 2015; Hirt and
Sherrard, 2015). Notably, T. vaginalis has shown a strong clinical
association with two different species of Mollicutes: Mycoplasma
hominis (Koch et al., 1997), and more recently with Candidatus
Mycoplasma girerdii (Martin et al., 2013; Fettweis et al., 2014).
Although little is currently known about the medical importance
of Candidatus M. girerdii (Fettweis et al., 2014), M. hominis is
considered a commensal organism of the lower urogenital tract
that is increasingly recognized as an opportunistic pathogen,
causing genital infections linked with several pregnancy and
postpartum complications including spontaneous abortion,
endometritis and low birth weight (Capoccia and Baud, 2013).
Intriguingly a number of studies have demonstrated a symbiotic
interaction between T. vaginalis and M. hominis. In fact more
than 80% of T.vaginalis isolates tested so far are naturally
infected by M. hominis, independently from their geographic
origin (Rappelli et al., 1998, 2001; Dessì et al., 2005, 2006). The
interaction between T. vaginalis and M. hominis is the first
symbiosis described involving two obligate human mucosal
microbes that can produce independent diseases in the same
anatomical area. However, the exact nature and fundamental
aspects of this microbial symbiosis, and in particular its potential
impact on the human host, still have to be clarified.
In recent years some aspects of the association between the
two pathogens have been characterized. M. hominis has the
capability to associate with T. vaginalis both at the cell surface
and intracellularly, and to replicate in a coordinated fashion
(Dessì et al., 2005). Moreover, mycoplasmal infection can be
passed from naturally mycoplasma-infected trichomonads to
naturally mycoplasma-free trichomonad isolates and to human
cervical cells (Rappelli et al., 2001). These data suggest that T.
vaginalis could play the role of a “Trojan horse” for the bacterium
during parasite infections, since the intracellular location of
M. hominis in T. vaginalis cells may contribute to protect
the bacteria from the host immune system and possibly from
antibiotics unable to cross cellular membrane (Dessì et al., 2005,
2006). In addition, M.hominis is resistant to anti-trichomonad
drugs as metronidazole and tinidazole. Data from in vitro
experiments indicate that M. hominis induces higher level of T.
vaginalis cytopathogenicity to vaginal epithelial cells, amoeboid
transformation rates and yeast phagocytosis (Vancini et al.,
2008) and that the presence of the bacteria synergistically up-
regulates the pro-inflammatory response of human macrophages
exposed to T. vaginalis (Fiori et al., 2013). Trichomonas vaginalis
and M. hominis also show a common biochemical pathway,
the Arginine Dihydrolase (ADH) pathway (Yarlett et al., 1996).
In both organisms, arginine is converted to ornithine and
ammonia through the enzymes arginine deiminase (ADI),
catabolic ornithine carbamyltransferase (OCT) and carbamate
kinase (CK), and finally ATP is generated by depletion of nitrogen
from amino acids. ADI are important enzymes implicated in
several bacterial infections (Ryan et al., 2009; Fulde et al., 2011)
and recently have been shown to be involved in virulence and
pathogenicity of the mucosal gut microbial parasite Giardia
duodenalis (Banik et al., 2013). In T. vaginalis ADI is localized
in hydrogenosomes while the other enzymes of the ADH
pathway are cytosolic (Figure 1; Morada et al., 2011). This is
the major energetic pathway of M. hominis (Pereyre et al.,
2009), while T. vaginalis uses it to acquire up to the 10% of its
energy requirements (Yarlett et al., 1996). Notably, T. vaginalis
co-cultured with M. hominis showed an increase in arginine
consumption and in ornithine and putrescine production, as
compared to mycoplasma-free T. vaginalis (Morada et al., 2010).
The benefit for M. hominis could be an increased supply
of putrescine, which the bacteria cannot synthesize and that
is important for normal cellular growth (Shah and Swiatlo,
2008). For T. vaginalis the physiological advantage of this
metabolic interaction is debatable but, given that T. vaginalis
in symbiosis with M. hominis consume larger amounts of
free arginine compared to trichomonads alone (Morada et al.,
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FIGURE 1 | A model for the arginine dihydrolase pathway in the T. vaginalis and M. hominis symbiosis. The enzymes involved in the ADH pathway in
T. vaginalis (flagellated cell on the top left with one of its hydrogenosome highlighted at the bottom where ADI is located; Morada et al., 2010) and in M. hominis (red
cell on the top right) have been reported for both organisms (Shah and Swiatlo, 2008; Morada et al., 2010). The locus tags TVAG_467820; TVAG_344520;
TVAG_183850 (T. vaginalis) and MH_0690 (M. hominis) for the genes encoding the enzymes of the ADH pathway are indicated. Arginine is hydrolytically cleaved to
citrulline by arginine deaminase (ADI, EC 3.5.3.6), and citrulline undergoes phosphorolysis by catabolic ornithine carbamiltransferase (OCT, EC 2.1.3.3) to ornithine
and carbamyl phosphate. Ornithine is converted in putrescine by ornithine decarboxylase (ODC, EC 4.1.1.17) and carbamyl phosphate is broken down by a catabolic
carbamate kinase enzyme (CK, EC 2.7.2) to bicarbonate and ammonia with concomitant production of ATP.
2010), a metabolic association could contribute to down-regulate
arginine dependent host innate defenses. Indeed, depletion of
arginine from the extracellular environment is considered a
virulence mechanism allowing several pathogens to interfere
with antimicrobial nitric oxide (NO) production by human
macrophages (Bronte and Zanovello, 2005; Das et al., 2010; Gogoi
et al., 2015).
The symbiosis between these two human associated
cellular microbes, both with pathogenic potential, represents a
fascinating example of poly-microbial infection, highlighting
the increasingly recognized complexity of host-microbes
interactions with important implications for how basic research
on host-parasite interactions is performed and that ultimately
will impact on future diagnostics and therapeutic strategies for
sexually transmitted infections (Clemente et al., 2012; Fichorova
et al., 2012, 2013; Bär et al., 2015; Hirt and Sherrard, 2015;
Kissinger, 2015). Here we aimed at gaining further insights into
the potential influence of T. vaginalis-M. hominis symbiosis on
the physiology and pathobiology of the parasite. We studied
in vitro the effects of M. hominis on T. vaginalis growth rate
and ATP concentration and investigated how the presence of
M. hominis may influence the hemolytic activity of the parasite,
since recently was demonstrated that T. vaginalis strain G3 has
the higher ability to induce red blood cells (RBCs) lysis compared
with other 25 trichomonas strains (Lustig et al., 2013). Finally, we
studied how the association between T. vaginalis andM. hominis
may influence NO production in a human monocytic cell line.
MATERIALS AND METHODS
Materials and Reagents
Cell culture media, RPMI 1640 with (1.15 mM L-Arginine) or
without L-Arginine were obtained from GIBCO and Sigma-
Aldrich, respectively. Lipopolysaccharides from Escherichia coli
055:B5, recombinant human IFN-γ produced in E.coli, the Griess
reagent and Phorbol-12-myristate -13- acetate (PMA) were all
purchased from Sigma-Aldrich. Fetal bovine serum (FBS) was
purchased from GIBCO.
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Parasites and Culture Conditions
T. vaginalis reference strain G3, naturally mycoplasma-free, and
isogenic G3 strain experimentally associated with M. hominis
isolate (MPM2) were cultured by daily passages at 1:16 in
Diamond’s TYM (trypticase, yeast extract and maltose) medium
supplemented with 10% FBS at 37◦C in a 5% CO2 atmosphere
(Diamond, 1957).M. hominis cells (named MPM2) were isolated
from the naturally infected T. vaginalis strain TvMPM2 as
previously described (Rappelli et al., 2001), maintained in
BEA medium (2.2% heart infusion broth;, 15% horse serum;
1.9% yeast extract; 40 IU/ml benzylpenicillin; 0.23% L-arginine;
0.0023% phenol red, pH 7.2) (Andersen et al., 1987).
In order to obtain an isogenic mycoplasma-infected
trichomonad strain, T. vaginalis G3 was stably infected with
M. hominis MPM2 as previously described (Morada et al.,
2010). Briefly, 1 ml of an overnight culture of M. hominis,
corresponding to approximately 109 color-changing units
(CCU), was added daily to a 10-ml mid-log phase culture of
the M. hominis-free T. vaginalis isolate G3 for 5 days in TYM
complete medium. Parasites were subsequently cultivated for 10
days with 1:16 daily passages in TYM complete medium. Stable
infection by M. hominis was then assessed by PCR with specific
primers (Blanchard et al., 1993) and by isolating in liquid and
solid BEA medium M. hominis from T. vaginalis cultures. The
stably infected T.vaginalis isolate has been named G3-MPM2.
Growth curves of M. hominis-free and isogenic M. hominis-
infected protozoa were compared. Briefly, 400,000 parasite cells
were inoculated in 10 ml of TYM medium and incubated at
37◦C. Cell counts were recorded at 2, 6, 9, 12, 18, 24, 32 h after
inoculation. The experiments were performed three times, in
triplicate.
In order to avoid cross contamination, mycoplasma-free and
isogenic M. hominis-infected T. vaginalis G3 were separately
grown in distinct incubators, in all experiment described.
Haemolytic Activity of M. hominis-Infected
Strains
T. vaginalis G3 associated with M. hominis isolate (MPM2) was
contrasted with isogenic T. vaginalis G3 naturally mycoplasma-
free, in order to evaluate haemolytic activity. Haemolysis
assays were performed as previously described (Fiori et al.,
1993). Briefly, RBCs were collected from healthy human
donors; erythrocytes were then washed three times in PBS and
immediately used. Parasites in exponential growth phase were
washed twice in PBS and resuspended to a density of 2 × 106
in PBS + 15 mM maltose (PBS-M). T. vaginalis G3 and G3
associated with MPM2 were incubated at 37◦C with washed
erythrocytes in a ratio 1:30 in PBS-M. The hemoglobin released
after incubation with red RBCs for different times ranging from
90 to 210 min, was evaluated by spectrophotometric analysis at
546 nm adsorbance. Haemolytic capacity ofM. hominis-infected
G3 strains was compared to parental uninfected isogenic T.
vaginalis G3.
In order to detect if M. hominis itself could be able
to lyse RBCs, 10 ml of overnight culture of M. hominis,
corresponding to approximately 1010 color-changing units
(CCU) were centrifuged, washed three times in PBS, resuspended
in 1ml PBS-M and incubated with 2× 106 RBCs at the same time
intervals.
Production of ATP in M. hominis-Infected
and M. hominis-Free T. vaginalis
The amount of intracellular ATP produced by mycoplasma-free
and mycoplasma-infected T. vaginalis G3 was evaluated in three
different phases of growth: lag, exponential, and stationary phase.
Furthermore, the amount of ATP produced by microorganisms
grown in media additioned with 0.1 mM or 0.5 mM L-Arginine
was also compared. A total of 15,000 cells of the parasites in
exponential growth phase for each tested condition was harvested
and centrifuged at 4000 × g for 10 min and the amount of ATP
analyzed in 50 µl by using CellTiter-Glo Luminescent Cell Assay
(Promega) according to the manufacturer’s instructions.
Cell Cultures and THP-1 Differentiation
Human monocytic cell line THP-1 (ATCC R© TIB202TM) was
cultured in RPMI 1640 or RPMI 1640 without L-Arginine,
supplemented with 10% FBS at 37◦C in a humidified atmosphere
containing 5% CO2 and maintained at 5 × 10
5 cells/ml. THP-
1 cells were seeded at 5 × 105 cells per well in 24-well plates
and differentiated to a macrophage-like phenotype (dTHP-1) by
stimulation with 50 ng/ml PMA for 18 h. Medium was replaced
and cells were maintained with two daily medium changes for
further 5 days before co-culture with protozoa.
Production of NO by Human Macrophages
Stimulated with M. hominis-Infected and
M. hominis-Free T. vaginalis
dTHP-1 cells seeded at 5 × 105 cells per well in 24-well plates,
were stimulated with T. vaginalis G3 or G3-MPM2 with 1:10
T. vaginalis/macrophage ratio, in presence of 100 Units/ml INF-
γ (Park et al., 1997) in RPMI 1640 (standard 1.15 mM arginine).
Untreated dTHP-1 and dTHP-1 stimulated cells with 1 µg/ml of
LPS were used as negative and positive controls respectively.
In a second group of experiments, dTHP-1 were depleted
of their intracellular L-arginine store by cultivation in RPMI
1640 without L-Arginine for 60 h; dTHP-1 cells were then co-
incubated withT. vaginalisG3 andwith G3-MPM2 in RPMI 1640
containing 0.5 mM and 0.1 mM L-arginine (final concentration).
To evaluate the ability of M. hominis alone to induce NO
release from macrophages, we have stimulated dTHP-1 with
cell-free supernatant of M. hominis-infected protozoan cultures,
filtered with 0.45 and 0.22 µm pore size filters, containing and
not containing bacteria respectively.
The amount of NO produced by dTHP1 cells after stimulation
with pathogens was determinedmeasuring the nitrite levels in the
culture medium through the Griess reaction (Park et al., 1997).
Briefly, culture mediumwas removed, centrifuged at 4000× g for
10min and nitrite levels measured in supernatants. Equal volume
of supernatants and Griess reagent (0.1% naphthylenedamine
dihydrochloride, 1% sulphanilamide and 2.5% H3PO4) was
incubated for 15 min at room temperature in the dark. The
absorbance was measured at 540 nm in an ELISA reader. Nitrite
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concentration (µM range) was determined using NaNO2 as
standard.
Statistical Analysis
All experiments were carried out at least in triplicate.
Statistical analyses were performed using unpaired Student t-
test (SigmaPlot version 12.0, from Systat Software, Inc., San
Jose California USA and Microsoft Excel; Microsoft, Redmond,
Washington, USA). A p < 0.05 was considered significant.
RESULTS
Effect of M. hominis on T. vaginalis
Cultures
The growth rate of M. hominis-free (G3) and M. hominis-
infected T. vaginalis (G3-MPM2) in complete Diamond’s TYM
medium, routinely used to grow the parasite, was compared.
Cells were cultured for a total of 32 h and T. vaginalis infected
withM. hominis were characterized by ∼ 20% faster growth rate
than mycoplasma-free parasites, leading to a ∼40% higher cell
densities in the stationary phase (Figure 2).
Effect of M. hominis on Haemolytic Activity
of T. vaginalis
We tested whether M. hominis might influence the hemolytic
properties of T. vaginalis in vitro, by using a haemolysis assay
(Fiori et al., 1993). The amount of hemoglobin released by
RBCs upon contact with pathogens was evaluated at time
intervals ranging from 90 to 210 min. The protozoa infected
withM. hominisMPM2 were characterized by higher haemolytic
activities compared to the mycoplasma-free isogenic T. vaginalis
G3 strain (Figure 3).
Control experiments to exclude direct haemolytic activity of
M. hominisMPM2, clearly indicated that the bacteria were unable
to lyse RBCs.
T. vaginalis Symbiotically-Associated with
M. hominis Produces Higher Amounts of
ATP
Since T. vaginalis can use arginine as an additional source
of energy via the ADH pathway (Morada et al., 2010), and
M. hominis utilizes the same metabolic pathway as its main
source of ATP (Pereyre et al., 2009), we have investigated
the possibility that M. hominis influences the amount of
ATP produced in the context of the T. vaginalis-M. hominis
consortium. The amount of ATP produced by T. vaginalis G3-
MPM2 is approximately 2-fold higher than that produced by
isogenic G3 in all growth phases for the tested growth conditions
(Figure 4). We asked next whether arginine concentration in
growth medium could influence ATP production in both M.
hominis infected and uninfected T. vaginalis. The experiments
were performed adding 0.1 mM or 0.5 mM L-Arginine to
the growth medium. The ATP produced by T. vaginalis
G3 cells grown in medium supplemented with arginine is
FIGURE 2 | The influence of M. hominis MPM2 on T. vaginalis growth curves. The starting point for both growth experiments was 400,000 parasite cells/ml
and data were collected at indicated times. The rate of replication of T. vaginalis associated with M. hominis is higher than the parasite alone, suggesting an important
influence by the bacteria on the parasite physiology. The results represent the average of three independent experiments and error bars represent standard deviations.
Statistical significance was tested by Student t-test and *p < 0.05 was considered significant. The growth curves for T. vaginalis G3 and T. vaginalis in symbiosis with
M. hominis MPM2 were obtained by fitting the data using a non-linear regression.
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only marginally increased compared to parasites grown in
the standard medium. In contrast, additional arginine leads
mycoplasma-infected parasites to produce significantly higher
amount of ATP (Figure 5).
M. hominis-Infected T. vaginalis Competes
with Host Macrophages for Arginine
Uptake and Down Regulates NO
Production
Depletion of host arginine is considered as a microbial virulence
strategy preventing toxic NO formation by macrophages.
Hence we evaluated NO production in human macrophages
FIGURE 3 | The impact of M. hominis symbiosis on T. vaginalis
haemolytic activity. Haemolytic activity exerted by M. hominis-infected
T. vaginalis G3 and uninfected T. vaginalis G3 was compared by analysing
hemoglobin released by RBCs through spectrophotometric analysis (reading
at 546 nm absorbance). The values define hemoglobin released by RBCs
upon contact with pathogens and represent average and error bars standard
deviations for three independent experiments. Statistical significance was
tested by Student t-test and * indicate significant (p < 0.05) variations
compared to parasites without M. hominis.
stimulated with T. vaginalis-associated and non-associated with
M. hominis. THP-1 cells were differentiated to a macrophage-
like phenotype by PMA (dTHP-1) and were thereafter incubated
with T. vaginalis G3 or T. vaginalis G3-MPM2, with 1:10
T. vaginalis/macrophage ratio for both conditions in medium
with high concentration of arginine (1.15 mM in RPMI 1640).
The supernatants were harvested 24 h after microbial stimulation
and the amount of NO was evaluated. We observed higher
secretion of NO upon dTHP-1 stimulation with T. vaginalis G3-
MPM2, compared to mycoplasma-free isogenic trichomonads
(Figure 6).
To evaluate the effects of M. hominis alone, cell-free
supernatants from MPM2-infected T. vaginalis filtered with
0.45µm, and 0.22µmpore size filters (that completely eliminates
bacteria) were incubated with THP-1 cells, as previously
described. After 24 h stimulation, macrophages incubated with
supernatants filtered with 0.45 µm pore size filters, produced
NO amounts comparable with stimulation with LPS and INF-γ
range from 0.07 to 0.08 µM), while THP-1 cells incubated with
0.22µmpore size filtered supernatants, were not stimulated (data
not shown).
These data indicate that bacterial symbionts up-regulate NO
production by macrophages, reminiscent of the synergistic effect
of the T. vaginalis-M. hominis symbiosis on macrophages pro-
inflammatory response in vitro (Fiori et al., 2013).
In order to test if arginine metabolism of symbionts M.
hominis could contribute to subtraction of this amino acid and,
by consequence, inhibit NO production by macrophages, THP-1
cells were differentiated (dTHP-1 cells) and cultured in arginine-
free media to deplete arginine intracellular stores. dTHP-1 were
then stimulated with T. vaginalis or T. vaginalis-M. hominis
consortium in presence of either 0.1 or 0.5 mM of arginine. These
two concentrations were chosen as the vaginal concentration
of arginine has been reported to be ∼0.2 mM and reduced to
undetected level during T. vaginalis infections or BV (Chen et al.,
1982). In our experimental conditions we observed a strong
FIGURE 4 | Intracellular amount of ATP produced by T. vaginalis and T. vaginalis infected with M. hominis in different growth phases. (A: lag phase; B:
exponential phase; C: stationary phase). The amount of ATP produced by the T. vaginalis-M. hominis (G3-MPM2) consortium is higher than that produced by T.
vaginalis (G3) alone in all growth phases. The total amount of ATP, corresponding to the number of cells tested (15,000 cells), is proportional to luminescent signal
generated by luciferase reaction. RLU corresponds to Relative Light Units. Bars represent the mean ±S.D. of at least three independent experiments. Data were
analyzed by Student’s t-test. *p < 0.05 when intracellular amount of ATP produced by G3-MPM2 is compared to amount of ATP produced by G3.
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FIGURE 5 | ATP produced by T. vaginalis and T. vaginalis–M. hominis growth in media with different concentration of arginine. The microorganisms were
grown in media supplemented with different concentrations of arginine, compared with the same strains cultured in normal Diamond’s medium. M. hominis infected
trichomonads cells lead to an approximately 2-fold increase in ATP production compared to T. vaginalis grown alone, both in normal Diamond’s medium and in
medium complemented with higher concentration of arginine. G3, naturally mycoplasma-free T. vaginalis; G3/MPM2, symbiotically-associated T. vaginalis G3 and M.
hominis MPM2. Analyzes represent averages of three independent triplicate experiments. Data were analyzed by in R (*p < 0.05) using a Linear mixed-effects model
fit by REML.
decrease in production of NO by macrophages stimulated with
T. vaginalis G3-MPM2, especially in presence of the lower
arginine concentrations (Figure 7).
The amount of NO released by macrophages after stimulation
with filtered supernatants from mycoplasma-free and
mycoplasma-infected T. vaginalis in arginine-free media is
undistinguishable compared with NO stimulation in medium
with arginine (data not shown).
These results suggest that T. vaginalis associated with
M. hominis could compete with macrophages to uptake free
arginine from the environment, leading to a significant down-
regulation of NO production.
DISCUSSION
It is increasingly recognized that complex poly-microbial
interactions involving the parasite T. vaginalis, its viruses (TVV)
(Goodman et al., 2011), members of the vaginal microbiota
and bacteria associated with BV, including a range of bacteria
with pathogenic potentials such a M. hominis, can influence the
mucosal inflammatory tone and general integrity (Rappelli et al.,
2001; Brotman et al., 2012; Fichorova et al., 2013; Bär et al., 2015).
This is thought to significantly increase both transmission rates of
important human viral STI including HIV and HPV (Guenthner
et al., 2005; McClelland et al., 2007; Thurman and Doncel, 2011;
Fichorova et al., 2013; Tao et al., 2014; Hirt and Sherrard, 2015;
Kissinger, 2015) and contribute to adverse pregnancy outcomes
(Fichorova, 2009; Hirt and Sherrard, 2015). In this scenario the
capacity of T. vaginalis and M. hominis to enter in a unique
form of symbiosis, combined with data supporting a model of
co-pathogenesis (Vancini et al., 2008; Fiori et al., 2013) and
metabolic symbiosis (Morada et al., 2011) is of particular interest
and led us to further investigate how M. hominis associated
with T. vaginalismight influence the parasite physiology and the
dynamic of host-parasite-bacteria interactions.
We establishing an experimental parasite-bacteria consortium
with a M. hominis clinical isolate (MPM2) to performed
comparative growth experiments in rich medium. We
demonstrated a significant higher growth rate in the log
phase and cell density in the stationary phase for the parasite-
bacteria consortium compared to the parent isogenic T. vaginalis
G3 strain grown over the course of 32 h. Notably a period of
adaptation was required (4 weeks) for the parasite-bacteria
consortium to develop a stable symbiotic association, with the
initial growth of the parasite being reduced during the early
interactions between parasite and bacteria.
Vancini and colleagues demonstrated that T. vaginalis
naturally infected by M. hominis were characterized by a higher
level of cytopathogenicity in vitro, compared to protozoa alone
(Vancini et al., 2008). To avoid any strain-to-strain variability, we
performed haemolysis experiments by using isogenic protozoa
with and without M. hominis and RBCs as target cells and
our data confirm that mycoplasmas enhance the parasite
cytopathogenicity, measured through the haemolytic properties
of T. vaginalis in vitro. These results could be explained by the
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FIGURE 6 | NO produced by human macrophages after co-culture with pathogens. The amount of NO produced by dTHP-1 cultivated RPMI 1640 containing
standard arginine concentration (1.15 mM) after 24 h of exposure to T. vaginalis G3 and T. vaginalis G3-MPM2 was compared. Experiments were carried out with 10:1
macrophages to parasites ratio. dTHP-1 cells produce higher amount of NO in response to stimulation with T. vaginalis G3-MPM2 (MØ:G3/MPM2) compared to
M. hominis-free isogenic T. vaginalis (MØ:G3). The values represent averages of at least three independent experiments. Data were analyzed by Student’s t-test
(*p < 0.05). dTHP-1 cells unstimulated and stimulated with LPS and INFγ represent negative and positive controls respectively.
FIGURE 7 | Effect of arginine on NO production by macrophages stimulated with pathogens. Arginine-depleted dTHP-1 (following cultivation in arginine-free
RPMI 1640), were incubated for 24 h with MPM2-free (MØ:G3), and MPM2-infected T. vaginalis (MØ:G3/MPM2) in presence of two different arginine concentration
(0.1 and 0.5 mM respectively). Experiments were carried out with 10:1 macrophages to parasites ratio. There is a significant reduction of NO produced by dTHP-1
incubated with T. vaginalis G3-MPM2. Results demonstrate that the metabolism of M. hominis contributes to consume the arginine in the medium. Analyzes represent
averages of three independent triplicate experiments. Data were analyzed in R (*p < 0.05) using a Linear mixed-effects model fit by REML.
up-regulation of T. vaginalis haemolysis due to the presence of
the symbiotic bacteria; for example by increasing the secretion
of T. vaginalis pore forming proteins (Fiori et al., 1996; Hirt et al.,
2011), or by increasing the adhesion of the parasite to RBCs in the
presence of theM. hominis. The characterization of themolecules
and mechanisms mediating haemolysis will be required to shed
light on these different hypotheses.
The observed boost in parasite growth rate and the higher cell
density in the log phase are consistent with a metabolic symbiosis
putatively based on arginine catabolism (Morada et al., 2011)
leading to an overall more efficient exploitation of metabolites
from the medium by the combined activity of the symbionts.
Arginine is rapidly depleted from the medium during T. vaginalis
cultivation (Linstead and Cranshaw, 1983; Zuo et al., 1995) and it
is degraded byADHpathway, leading to ornithine and putrescine
production and final generation of ATP (Yarlett et al., 1996). The
production of ATP by ADH pathway has advantages over glucose
fermentation since the end product putrescine is non acidic;
recently Huang and colleagues have shown that two enzymes
involved in this pathway, catabolic ornithine carbamyltransferase
(OCT) and carbamate kinase (CK), are up-regulated in the log
growth phase of T. vaginalis under glucose restriction (GR),
suggesting that this energy–producing pathway is important
under GR (Huang et al., 2014). In M. hominis, ADH is the
major energetic pathway (Pereyre et al., 2009) since arginine
is the major source of energy (Pereyre et al., 2009) and it is
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essential for initiation of bacteria growth (Hahn and Kenny,
1974). The parasite-bacteria consortium, characterized by two
ADH pathways of distinct evolutionary origins (Morada et al.,
2010), exhibits increased arginine consumption, concomitant
with increase of ornithine and putrescine production (Morada
et al., 2010). We contrasted the amount of intracellular ATP
present in T. vaginalis in the presence and absence ofM. hominis
in different growth phases and under different environmental
arginine concentrations. The results show higher amounts of
ATP in the parasite in the presence of the bacteria compared
withM. hominis-free parasites, in all growth phases. Interestingly,
addition of free arginine to culture medium led the T. vaginalis-
M. hominis consortium to be characterized by a further increase
in the amount of ATP per cell. It has been demonstrated that an
high ATP content in cell cultures is correlated with an increased
growth rate of parasites, including T. vaginalis (Miyahira and
Takeuchi, 1991), supporting our hypothesis that the presence of
M. hominismay enhance growth rate of T. vaginalis by increasing
intracellular ATP. The overall observed increase of ATP per cell
in the T. vaginalis-M. hominis consortium might be due to ATP
produced by mycoplasmas through the ADH pathway, since
the increment of ATP production is positively associated with
arginine concentration, and the expression of all T. vaginalisADI
genes is not up-regulated by the bacterial symbionts (Morada
et al., 2010). But as the growth rate of the parasite is boosted, a
fraction of the increase of ATP could be directly associated with
the parasite itself rather than the bacteria only. Characterizing
the potential metabolic interactions between the bacteria and the
parasite will be required to establish the origin of the increase of
ATP and the link between higher ATP and higher growth rate of
the parasite in the T. vaginalis-M. hominis consortium.
In human macrophages, arginine is the exclusive amino acid
substrate for the production of NO by all isoforms of NO
synthase (NOS). Regulating arginine availability is a potential
defensive mechanism of pathogens, that can lead to the control
of NO production (Popovic et al., 2007). Depletion of arginine is
a common strategy used by many pathogens to escape immune
response and there are several microbial enzymes, such as
arginase and arginine deiminase, that compete for arginine with
host NOS (Das et al., 2010). Several studies suggested a role
of ADI in microbial virulence (Ryan et al., 2009; Fulde et al.,
2011) and recently Banik and colleagues have shown that ADI
is implicated in the virulence of Giardia duodenalis (Banik et al.,
2013). Moreover, Noh and colleagues have proposed a role
for M. hominis ADI in suppression of NO production caused
by macrophage-inducible NO synthase (Noh et al., 2002). The
macrophage cytotoxicity against T. vaginalis is regulated by NO
(Park et al., 1997), as well as by proinflammatory cytokines,
such as IL-1, IL-6 and TNFα via NF-kB (Han et al., 2009)
and the presence of M. hominis is implicated in the robust
increase of inflammatory mediators by macrophages (Fiori
et al., 2013). Hence, we hypothesized a competition between
parasites and macrophages in the uptake of free arginine from
the environment. Experiments of co-culture between dTHP-1
cells and T. vaginalis associated and non-associated with M.
hominis, in presence of different concentration of arginine, were
performed. Results obtained show that in presence of high
concentration of environmental arginine the NO production
by macrophages is up regulated by the T. vaginalis-M. hominis
consortium, confirming our previous data on synergistic effect
of the parasite-bacteria consortium on the proinflammatory
response (Fiori et al., 2013). On the contrary, when macrophages
were depleted of their intracellular arginine stores by cultivation
in arginine-free media, and then stimulated with mycoplasma-
free and mycoplasma-infected T. vaginalis in presence of 0.1 or
0.5 mM of arginine, a strong decrease in NO production was
reported in macrophages stimulated with the parasite-bacteria
consortium. The competition for free arginine uptake between
the T. vaginalis-M. hominis consortium and phagocytes, strongly
reduce nitric oxide production by macrophages.
These data led us to speculate that symbiosis between
T. vaginalis andM. hominis influence host-microbes interactions
to the benefit of both microbial partners during infections.
M. hominis might play a key role in inflammation during
trichomoniasis, by interfering with NO production by human
macrophages through outcompeting the human cells for the key
substrate arginine.
These hypotheses are strongly supported by recent studies
that show how the interaction between T. vaginalis and vaginal
microbiota potentially influence the outcomes of trichomoniasis.
The parasite was found to limit different species of Lactobacillus,
associated with bacterial vaginosis (Fichorova et al., 2013). It has
been shown that the presence of Lactobacillus gasseri significantly
inhibits T. vaginalis adhesion to human cells in strain–specific
and contact dependent manners (Phukan et al., 2013). Moreover,
Gardnerella vaginalis and Atopobium vaginae, two common
mucosal bacteria associated with bacterial vaginosis, can amplify
the pro-inflammatory response to protozoan molecules and to
TVV (Fichorova et al., 2013).
Here we studied the effects of a single strain of M. hominis in
symbiosis with the T. vaginalis strain G3, that leads to mutualistic
inter-microbial interactions with a potential synergistic impact
on their pathobiology on their human host. In order to evaluate
whether these results represent a typical outcome of M. hominis
- T. vaginalis interactions, further experiments with additional
combinations of bacterial and parasite strains will be required.
In conclusion, these findings taken together support a model
in which sinergistic association between vaginal mucosal bacteria
and T. vaginalis might influence trichomoniasis health sequelae,
supporting both the growth of associated pathogenic bacteria and
increasing the inflammatory response for disease development.
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